FEDERALSEC 10-K Item 1CFirst filing
Filed Mar 29, 2024bd_b89caff4d27bc30c
Actinium Pharmaceuticals' Item 1C disclosure in its Form 10-K describes the company's cybersecurity risk management program, governance structure (CFO-led, board audit-committee oversight), use of third-party advisors, incident response policy, and cyber liability insurance. The filing explicitly states that to date the company has not experienced any material cybersecurity incident affecting operations or financial condition. No breach event is disclosed.